ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced updated efficacy and safety ...
Friday, ImmunityBio said the two complete responses are ongoing after seven and 15 months. The patients received four cycles ...
ImmunityBio, Inc. is upgraded to Buy reflecting improving Anktiva data & potential label expansions in NMIBC and NSCLC. Read ...
Cold weather can drain energy and weaken immunity. Try these 6 yoga poses to support the immune system, blood circulation, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback